Date: Wednesday, May 23rd, 2018
Time: 10am PDT (1pm EDT)
Duration: 60 minutes


In a recent Tufts CSDD survey of global sponsors on Oversight, Clinical Operations executives called out “improving study and CRO performance and productivity” as top priorities. In order to achieve these goals, they need to assess both portfolio and study data accurately and efficiently.
oversight objectives
Join Linda Sullivan of Metrics Champion Consortium and Comprehend for an insightful discussion on recent metrics research that uncovered how various aggregation styles and views of study-level data can be used to monitor portfolio-level plans and timelines.  The webinar will discuss both advantages and disadvantages of various study data views, and ways in which Sponsors can evaluate study data collaboratively with their vendor partners.

Additionally, attendees will see a live demonstration of how leading sponsors can easily aggregate and manage study data using purpose-built automation. With real-time, accurate dashboards and metrics, sponsors can increase their speed to a quality result.

Featured Speakers:


Julie Peacock, Clinical Intelligence Expert, Comprehend

Closely aligned with customers and the sales organization, Julie focuses on enabling prospects and customers on Comprehend’s Clinical Intelligence solutions. She manages go to market strategy, sales enablement, and product marketing.

Prior to Comprehend, Julie spent 18 years at Oracle Corporation in the enterprise application space where she managed strategy, field enablement and launch activities for a series of BtoB solutions. Julie holds a bachelor’s degree in Marketing from Auburn University.



Linda B. Sullivan, Co-founder and President, Metrics Champion Consortium

Ms Sullivan is Co-Founder & President of the Metrics Champion Consortium (MCC), an industry association dedicated to leading the drug-development enterprise in the adoption and utilization of standardized metrics and benchmarks to drive performance improvement. She has been a featured speaker at Performance Metrics, Risk-Based Monitoring, Quality Management & Clinical Trial Oversight industry meetings.

Ms Sullivan received a B.S. in Biology from Trinity College and a M.B.A. from Dartmouth College where she was named a Tuck Scholar.

comprehend logo.png MCCLogoHiRes 2-1.png